| scholarly article | Q13442814 |
| P2093 | author name string | Jun Zhang | |
| Douglas H Smith | |||
| David F Meaney | |||
| Xiao-Han Chen | |||
| Rasmus Rojkjaer | |||
| Sherman C Stein | |||
| Victoria E Johnson | |||
| Kevin D Browne | |||
| Jason Huang | |||
| Robert F Groff | |||
| Eric D Schwartz | |||
| P2860 | cites work | Serine proteases and brain damage - is there a link? | Q30305943 |
| The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation | Q33360627 | ||
| Recombinant activated factor VII for acute intracerebral hemorrhage. | Q34397275 | ||
| Diffuse axonal injury in head trauma | Q34459202 | ||
| Successful use of recombinant activated factor VII for trauma-associated hemorrhage in a patient without preexisting coagulopathy | Q34522223 | ||
| The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients | Q34817997 | ||
| Long-term accumulation of amyloid-beta, beta-secretase, presenilin-1, and caspase-3 in damaged axons following brain trauma | Q35103035 | ||
| A cell-based model of coagulation and the role of factor VIIa | Q35617165 | ||
| Moderate and severe traumatic brain injury: epidemiologic, imaging and neuropathologic perspectives | Q35802472 | ||
| Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding | Q35839531 | ||
| Delayed brain injury after head trauma: significance of coagulopathy | Q35905754 | ||
| Coagulopathy in traumatic brain injury | Q36262718 | ||
| Preclinical trauma studies of recombinant factor VIIa | Q36284643 | ||
| Effects of recombinant activated factor VII in traumatic nonsurgical intracranial hemorrhage | Q36592943 | ||
| Diffuse axonal injury in non-missile head injury | Q37274633 | ||
| Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage. | Q40519948 | ||
| Recombinant activated factor VII in children with acute bleeding resulting from liver failure and disseminated intravascular coagulation. | Q40620271 | ||
| Guidelines for the management of severe head injury. Brain Trauma Foundation | Q41348510 | ||
| Binding of alpha-thrombin to fibrin depends on the quality of the fibrin network | Q41909182 | ||
| Progressive hemorrhage after head trauma: predictors and consequences of the evolving injury | Q43856783 | ||
| Recombinant activated factor VII for adjunctive hemorrhage control in trauma | Q44472174 | ||
| Disseminated intravascular coagulation associated with massive brain injury | Q44545125 | ||
| Venous thromboembolism prophylaxis after head and spinal trauma: intermittent pneumatic compression devices versus low molecular weight heparin | Q45085263 | ||
| Factor VIIa for correction of traumatic coagulopathy | Q45130198 | ||
| Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma. | Q45858062 | ||
| The Effect of Recombinant Factor VIIa on Noncoagulopathic Pigs with Grade V Liver Injuries | Q45862242 | ||
| The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIX. | Q45863825 | ||
| Preferential localization of recombinant factor VIIa to platelets activated with a combination of thrombin and a glycoprotein VI receptor agonist | Q45865116 | ||
| Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A. | Q45882175 | ||
| Recombinant factor VIIa for the treatment of severe postoperative and traumatic hemorrhage | Q45882217 | ||
| Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force | Q45882922 | ||
| Platelet activity of high-dose factor VIIa is independent of tissue factor | Q45884609 | ||
| The effect of recombinant factor VIIa on coagulopathic pigs with grade V liver injuries | Q45888438 | ||
| Breakdown of the blood-brain barrier after fluid percussive brain injury in the rat. Part 1: Distribution and time course of protein extravasation | Q46304244 | ||
| Breakdown of the Blood–Brain Barrier After Fluid Percussion Brain Injury in the Rat: Part 2: Effect of Hypoxia on Permeability to Plasma Proteins | Q46576120 | ||
| Acute traumatic intraparenchymal hemorrhage: risk factors for progression in the early post-injury period | Q46954679 | ||
| Plasminogen activators potentiate thrombin-induced brain injury | Q47976056 | ||
| MR imaging of experimentally induced intracranial hemorrhage in rabbits during the first 6 hours | Q48170509 | ||
| Hematoma enlargement in spontaneous intracerebral hemorrhage | Q48197733 | ||
| Experimental investigation of cerebral contusion: histopathological and immunohistochemical evaluation of dynamic cortical deformation | Q48277556 | ||
| Modulation of hippocampal neuron survival by thrombin and factor Xa. | Q48358999 | ||
| Delayed and progressive brain injury in closed-head trauma: radiological demonstration | Q48363389 | ||
| Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. | Q48397525 | ||
| MR follow-up of small experimental intracranial haemorrhages from hyperacute to subacute phase | Q48623285 | ||
| Characterization of diffuse axonal pathology and selective hippocampal damage following inertial brain trauma in the pig | Q48675620 | ||
| Head-injured patients who talk and deteriorate into coma. Analysis of 211 cases studied with computerized tomography | Q48675734 | ||
| Treatment of severe coagulopathy after gunshot injury to the head using recombinant activated factor VII. | Q48791426 | ||
| Early hemorrhage growth in patients with intracerebral hemorrhage | Q48821770 | ||
| Factors associated with neurological outcome and lesion progression in traumatic subarachnoid hemorrhage patients. | Q48953684 | ||
| Antiapoptotic effect of coagulation factor VIIa. | Q51837430 | ||
| Mannitol pharmacokinetics and serum osmolality in dogs and humans. | Q52429650 | ||
| Traumatic brain injury | Q54273190 | ||
| Treatment of traumatic bleeding with recombinant factor VIIa. | Q55033461 | ||
| A prospective study of venous thromboembolism after major trauma. | Q55065749 | ||
| Effective Management of Refractory Postcardiotomy Bleeding With the Use of Recombinant Activated Factor VII | Q59259297 | ||
| Traumatic Brain Injury in the United States: A Public Health Perspective | Q61424636 | ||
| Evolving brain lesions in the first 12 hours after head injury: analysis of 37 comatose patients | Q70894547 | ||
| Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation | Q72887288 | ||
| Sequential computerized tomography changes and related final outcome in severe head injury patients | Q73468538 | ||
| Immediate coma following inertial brain injury dependent on axonal damage in the brainstem | Q74125872 | ||
| Control of life-threatening pulmonary bleeding with activated recombinant factor VII | Q77763143 | ||
| Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial | Q78840677 | ||
| Detection and appearance of intraparenchymal haematomas of the brain at 1.5 T with spin-echo, FLAIR and GE sequences: poor relationship to the age of the haematoma | Q80076066 | ||
| Recombinant factor VIIa increases the pressure at which rebleeding occurs in porcine uncontrolled aortic hemorrhage model | Q80347296 | ||
| Effects of increasing doses of activated recombinant factor VII on haemostatic parameters in swine | Q81402653 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | traumatic brain injury | Q1995526 |
| P304 | page(s) | 645-655 | |
| P577 | publication date | 2008-01-05 | |
| P1433 | published in | Experimental Neurology | Q5421127 |
| P1476 | title | Hemostatic and neuroprotective effects of human recombinant activated factor VII therapy after traumatic brain injury in pigs | |
| P478 | volume | 210 |
| Q41356124 | A Porcine Model of Traumatic Brain Injury via Head Rotational Acceleration |
| Q33694285 | Age Is a Determinant of Leukocyte Infiltration and Loss of Cortical Volume after Traumatic Brain Injury |
| Q39203875 | An in vivo, MRI-integrated real-time model of active contrast extravasation in acute intracerebral hemorrhage |
| Q35589949 | Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here? |
| Q27025951 | Animal models of traumatic brain injury |
| Q30476151 | Assessing learning and memory in pigs |
| Q30739121 | Diffusion tensor imaging and magnetic resonance spectroscopy in traumatic brain injury: a review of recent literature |
| Q88687080 | Factor VIIa administration in traumatic brain injury: an AAST-MITC propensity score analysis |
| Q95790496 | Folic acid enhances early functional recovery in a piglet model of pediatric head injury |
| Q35212583 | Mild traumatic brain injury and diffuse axonal injury in swine |
| Q30968544 | Pre-Clinical Traumatic Brain Injury Common Data Elements: Toward a Common Language Across Laboratories |
| Q39611127 | The influence of coagulation and inflammation research on the improvement of polytrauma care |
| Q64082897 | The pig as a preclinical traumatic brain injury model: current models, functional outcome measures, and translational detection strategies |
| Q36768885 | Therapy development for diffuse axonal injury |
| Q33581052 | Use of recombinant factor VIIa (rFVIIa) as pre-hospital treatment in a swine model of fluid percussion traumatic brain injury |
| Q84509682 | [Use of activated recombinant factor VII in patients with brain injury or undergoing brain surgery] |
Search more.